Your prescriber decides whether a medication is appropriate
To view or add a comment, sign in
The 60 mg vial size is intended to support extended, repeated, or high-volume laboratory protocols and does not represent a single human dosing level
Similar content being viewed by others Background Cardiovasular disease (CVD) is the world's leading cause of death, far outstripping infectious disease mortality from malaria, HIV/AIDS, and tuberculosis [1]
Real-world evidence suggests that these patients can benefit from semaglutide therapy when indicated for diabetes or weight management
If you are considering surgery while using a GLP-1 agonist, it is important to note that these medications impact how your body processes food and thus could influence both pre-operative preparations and post-operative recovery